202 related articles for article (PubMed ID: 30353031)
1. IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability.
Wang TT; Yang J; Zhang Y; Zhang M; Dubois S; Conlon KC; Tagaya Y; Hamele CE; Dighe S; Olson TL; Feith DJ; Azimi N; Waldmann TA; Loughran TP
Leukemia; 2019 May; 33(5):1243-1255. PubMed ID: 30353031
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia.
Brammer JE; Ballen K; Sokol L; Querfeld C; Nakamura R; Mishra A; McLaughlin EM; Feith D; Azimi N; Waldmann TA; Tagaya Y; Loughran T
Blood; 2023 Oct; 142(15):1271-1280. PubMed ID: 37352612
[TBL] [Abstract][Full Text] [Related]
4. Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.
Zhang M; Mathews Griner LA; Ju W; Duveau DY; Guha R; Petrus MN; Wen B; Maeda M; Shinn P; Ferrer M; Conlon KD; Bamford RN; O'Shea JJ; Thomas CJ; Waldmann TA
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12480-5. PubMed ID: 26396258
[TBL] [Abstract][Full Text] [Related]
5. Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21.
Ciszewski C; Discepolo V; Pacis A; Doerr N; Tastet O; Mayassi T; Maglio M; Basheer A; Al-Mawsawi LQ; Green PHR; Auricchio R; Troncone R; Waldmann TA; Azimi N; Tagaya Y; Barreiro LB; Jabri B
Gastroenterology; 2020 Feb; 158(3):625-637.e13. PubMed ID: 31622625
[TBL] [Abstract][Full Text] [Related]
6. Results From a First-in-Human Study of BNZ-1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (γc) Family of Cytokines.
Frohna PA; Ratnayake A; Doerr N; Basheer A; Al-Mawsawi LQ; Kim WJ; Zapata JC; Wu X; Waldmann TA; Azimi N; Tagaya Y
J Clin Pharmacol; 2020 Feb; 60(2):264-273. PubMed ID: 31465127
[TBL] [Abstract][Full Text] [Related]
7. CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
Ju W; Zhang M; Jiang JK; Thomas CJ; Oh U; Bryant BR; Chen J; Sato N; Tagaya Y; Morris JC; Janik JE; Jacobson S; Waldmann TA
Blood; 2011 Feb; 117(6):1938-46. PubMed ID: 21106989
[TBL] [Abstract][Full Text] [Related]
8. JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and posttranslationally in ATL cells.
Yamada O; Ozaki K; Akiyama M; Kawauchi K
Mol Cancer Ther; 2012 May; 11(5):1112-21. PubMed ID: 22402124
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL leukemia.
Olson KC; Kulling PM; Olson TL; Tan SF; Rainbow RJ; Feith DJ; Loughran TP
Cancer Biol Ther; 2017 May; 18(5):290-303. PubMed ID: 27715403
[TBL] [Abstract][Full Text] [Related]
10. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
Chetoui N; Boisvert M; Gendron S; Aoudjit F
Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
[TBL] [Abstract][Full Text] [Related]
12. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Matsuda T; Tanaka Y; Ohshiro K; Mori N
Retrovirology; 2006 Apr; 3():22. PubMed ID: 16603085
[TBL] [Abstract][Full Text] [Related]
14. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways.
de Totero D; Meazza R; Capaia M; Fabbi M; Azzarone B; Balleari E; Gobbi M; Cutrona G; Ferrarini M; Ferrini S
Blood; 2008 Jan; 111(2):517-24. PubMed ID: 17938255
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
[TBL] [Abstract][Full Text] [Related]
16. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.
Girardi T; Vereecke S; Sulima SO; Khan Y; Fancello L; Briggs JW; Schwab C; de Beeck JO; Verbeeck J; Royaert J; Geerdens E; Vicente C; Bornschein S; Harrison CJ; Meijerink JP; Cools J; Dinman JD; Kampen KR; De Keersmaecker K
Leukemia; 2018 Mar; 32(3):809-819. PubMed ID: 28744013
[TBL] [Abstract][Full Text] [Related]
17. Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders.
Shvidel L; Duksin C; Tzimanis A; Shtalrid M; Klepfish A; Sigler E; Haran M; Eilat E; Berrebi A
Hematol J; 2002; 3(1):32-7. PubMed ID: 11960393
[TBL] [Abstract][Full Text] [Related]
18. Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.
Waldmann TA; Chen J
Annu Rev Immunol; 2017 Apr; 35():533-550. PubMed ID: 28182501
[TBL] [Abstract][Full Text] [Related]
19. [Large Granular Lymphocytic Leukemia and JAK/STAT Signaling Pathway--Review].
Qiu ZY; Fan Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):254-60. PubMed ID: 26913432
[TBL] [Abstract][Full Text] [Related]
20. A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex.
Rafei M; Wu JH; Annabi B; Lejeune L; François M; Galipeau J
Blood; 2007 Mar; 109(5):2234-42. PubMed ID: 17082320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
